MARKET

NAGE

NAGE

Niagen Bioscience, Inc
NASDAQ
4.190
-0.780
-15.69%
Pre Market: 4.170 -0.02 -0.48% 04:41 05/08 EDT
OPEN
4.360
PREV CLOSE
4.970
HIGH
4.388
LOW
4.038
VOLUME
496
TURNOVER
0
52 WEEK HIGH
14.69
52 WEEK LOW
4.038
MARKET CAP
333.71M
P/E (TTM)
20.59
1D
5D
1M
3M
1Y
5Y
1D
Niagen Bioscience price target lowered to $12 from $13 at Roth Capital
TipRanks · 13h ago
Niagen Bioscience (NAGE) Receives a Buy from Ladenburg Thalmann & Co.
TipRanks · 19h ago
Analysts Offer Insights on Healthcare Companies: Medline (MDLN), Niagen Bioscience (NAGE) and BeOne Medicines (ONC)
TipRanks · 20h ago
Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga · 21h ago
Niagen Bioscience reports Q1 EPS 7c, consensus 6c
TipRanks · 1d ago
Niagen Bioscience sees 2026 sales growth 10%-15%
TipRanks · 1d ago
Niagen Bioscience Earnings Call Highlights Growth Push
TipRanks · 1d ago
Niagen Bioscience posts investor deck outlining NAD+ healthy-aging strategy
PUBT · 1d ago
More
About NAGE
Niagen Bioscience, Inc. is a global bioscience company dedicated to promoting healthy aging. Its segments include Consumer Products, Ingredients segment, Analytical Reference Standards and Services and Pharmaceuticals. The Consumer Products segment provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors. The ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and outsourcing facilities. The Analytical Reference Standards and Services segment offer the supply of phytochemical reference standards and other research and development services. The Pharmaceutical segment focuses on the pharmaceutical development of its nicotinamide adenine dinucleotide (NAD) precursor portfolio for potential therapeutic applications in rare diseases.

Webull offers Niagen Bioscience Inc stock information, including NASDAQ: NAGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAGE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAGE stock methods without spending real money on the virtual paper trading platform.